BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 18, 2009
View Archived Issues
Agile's low-dose levonorgestrel/ethinylestradiol contraceptive patch shows safety and efficacy
Read More
Positive clinical results reported for Archimedes' NasalFent fentanyl nasal spray for cancer pain
Read More
Novel c-Met and Ron kinase inhibitor, MK-8033, shows antitumor activity in preclinical studies
Read More
Clofarabine prodrug active in various tumor models
Read More
Heat shock protein 90 inhibitor CUDC-305 shows potent and lasting in vivo antitumor activity
Read More
Boehringer and DeveloGen sign agreement in diabetes, obesity and the metabolic syndrome
Read More
Bayer Schering launches oral contraceptive Qlaira in Europe
Read More
FDA approves Novartis' Prevacid 24HR for frequent heartburn
Read More
Allergan claims novel sphingosine 1-phosphate receptor ligands for the treatment of pain
Read More
Cardioxyl Pharmaceuticals and Johns Hopkins University claim novel compounds for heart failure
Read More
Boehringer Ingelheim reports discovery of chemokine CCR10 receptor antagonists as antipsoriatics
Read More
Polo-like kinase 1 inhibitors for cancer treatment presented by Nerviano Medical Sciences
Read More
CMV DNA vaccine may control post-transplant CMV viremia; interim phase II data disclosed
Read More
ImmuneRegen and University of Pittsburgh sign agreement for influenza drug Viprovex
Read More
FDA approves ActoGeniX's IND for phase Ib clinical trial of AG-013 in oral mucositis
Read More
DCGI grants approval to Piramal Life to initiate two phase I/II studies of cancer drug P-276
Read More
Oxygen Biotherapeutics signs LP-CRADA with NMRC and WRAIR for Oxycyte
Read More
Amgen presents Q1 product and pipeline update
Read More
Ablynx receives orphan drug designation and provides pipeline update
Read More
Intravitreal IBI-20089 reduces retinal thickness in cystoid macular edema patients in phase I trial
Read More
AGI releases results from phase III Rezular trial, plans to cease development in IBS-D
Read More
Nonsteroidal antiandrogen shows efficacy in castration-resistant prostate cancer in phase I/II trial
Read More
Antares presents preliminary phase II transdermal contraception results
Read More
Metabolic Solutions presents preliminary results from phase IIa MSDC-0160 trial
Read More
Novavax completes enrollment in second phase II seasonal influenza vaccine trial
Read More
Data show cardiovascular therapeutic potential for two Compugen peptides
Read More